Getting Started with Wegovy: What to Expect in the First Weeks

The myth that stops people giving it a fair chance

The single biggest misconception about starting Wegovy is that the first pen should produce noticeable results. It won't, and building that expectation leads to abandoning treatment far too early. The 0.25mg starting dose exists for one reason: to reduce nausea and other gastrointestinal discomfort while your system adapts to a GLP-1 receptor agonist. It is a tolerability dose. The medicine only reaches the dose range where significant appetite suppression is consistent once you've titrated through 0.5mg and 1.0mg on the way to 1.7mg and then 2.4mg maintenance.

The STEP 1 trial, published in the New England Journal of Medicine, found an average weight reduction of around 15% over 68 weeks at 2.4mg alongside lifestyle changes. That figure comes from the full duration at a therapeutic dose, not the first four weeks. Patience at the start isn't passive; it's clinically correct.

A second myth: that side effects mean you should stop. Nausea, loose stools and indigestion are common during dose escalation. They typically ease within a few days to two weeks as your body adjusts. If side effects feel severe or don't settle, your prescriber can slow the titration, and our guide to getting off Wegovy is also worth reading if you ever find yourself wondering what stopping the treatment properly involves. That's exactly why clinical oversight matters throughout, not just at the start.

What the titration schedule actually looks like week by week

Wegovy follows a fixed escalation pathway. Each step runs for roughly four weeks, giving your system time to adapt before moving up. The sequence runs: 0.25mg, then 0.5mg, then 1.0mg, then 1.7mg, and finally 2.4mg as the standard maintenance dose. If you tolerate each step well, the progression is steady. If you don't, your prescriber may extend a step, that's a clinical decision, not a failure.

The NHS medicines page for semaglutide sets out the licensed dose schedule clearly, and it's worth reading the patient information leaflet that comes with your pen before each injection. Injection sites (abdomen, thigh, upper arm) should be rotated to avoid skin reactions at any one spot.

Timing works best when it's consistent. Wegovy is a once-weekly injection and can be taken on any day of the week, at any time of day, with or without food. Many people pick a specific evening and tie it to an existing routine so the weekly rhythm becomes automatic. The pen lives in the fridge door; some patients note it next to their weekly food shop reminder. Whatever makes the habit stick is the right system for you.

Storage is straightforward until you're away from home. Wegovy must be kept refrigerated at 2–8°C before first use. The patient information leaflet specifies an exact window for room-temperature storage, always refer to that rather than general estimates, because the window differs by pen and presentation.

Who Wegovy is licensed for, and how eligibility is assessed

Wegovy holds a UK licence for weight management in adults with a BMI of 30 or above, or a BMI of 27–29.9 alongside at least one weight-related health condition such as high blood pressure, high cholesterol or prediabetes. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. The licence requires use alongside a reduced-calorie diet and increased physical activity, the medicine works alongside lifestyle change, not instead of it.

Eligibility for private treatment is assessed by a prescriber, not by ticking boxes on a form. A clinician reviews your health history, current medicines, contraindications (certain GI conditions, a history of pancreatitis, and others listed in the SmPC) and whether Wegovy is the right fit. That review happens before a prescription is written. Semaglutide and how it works covers the mechanism in more detail if you want the clinical background before your consultation.

Wegovy is not recommended during pregnancy, breastfeeding or when actively trying to conceive. It isn't licensed for anyone under 18. Women using oral contraceptives should discuss pill absorption with their prescriber, this is particularly relevant for tirzepatide but worth raising for any GLP-1 treatment. The NHS England guidance on weight-management injections covers the contraception and surgery considerations clearly.

Starting through a regulated online pharmacy

The only legal route to Wegovy in the UK is a prescription following clinical assessment. That applies whether you access treatment through your GP, an NHS specialist weight management service, or a GPhC-registered online pharmacy. What differs is the speed and the criteria. NHS access under NICE's appraisal (TA875) is routed through specialist services, and waiting lists in many areas are long. Getting Wegovy through an online clinic explains how private prescribing works and what to check before you commit to any provider.

For context on what Wegovy treatment typically costs privately, the Wegovy cost guide sets out the market honestly, including what a legitimate price covers, and if you want to make treatment more affordable from the outset, our Wegovy savings page outlines the options available to help reduce what you pay. If you've already read about Wegovy and want to understand the starting dose in detail, the Wegovy starter dose page focuses specifically on that first pen.

At nume, every consultation is read by a GPhC-registered Independent Prescriber on the same day it's submitted. No automated shortlisting; a real clinician reviews the whole picture. If treatment is approved, it's dispatched the same day for free next-working-day delivery. Check your eligibility and start your free consultation when you're ready.